SH23085High interest for long-acting injectable PrEP among men who have sex with men at most risk for HIV in San Francisco, 2021
Men who have sex with men bear the bulk of new HIV infections in the United States. Interventions such as pre-exposure prophylaxis (PrEP), a medication that prevents HIV when taken as directed, have reduced HIV infections greatly; however, there are gaps in protection. New tools such as a long-acting injectable form of PrEP can promote further drops in HIV incidence. In this study, we investigate who might be interested in transitioning to this new modality.